8-KLeadership ChangesOther EventsExhibits & Filings

BeOne Medicines Ltd. 8-K Report, Executive Changes (Mar 20, 2024)

Filed March 20, 2024For Securities:ONCBEIGF

Summary

BeiGene, Ltd. (ONC) announced a key change in its accounting leadership through an 8-K filing on March 20, 2024. The company has appointed Titus Ball as its new Principal Accounting Officer, effective March 19, 2024. Mr. Ball, who joined BeiGene in August 2023 as Vice President and Chief Accounting Officer, brings a strong background in accounting and finance from his previous roles at KPMG and Carlisle Companies Inc., including a tenure as VP & Chief Accounting Officer at Carlisle. This transition sees the responsibilities shift from CFO Julia Wang, who will continue in her roles as Chief Financial Officer and Principal Financial Officer. Additionally, the company's Board of Directors approved amendments to its Independent Director Compensation Policy. Effective April 1, 2024, the annual cash retainers for the chairperson and members of the Nominating and Corporate Governance Committee will see modest increases. Specifically, the chairperson's retainer will rise by $2,000 to $20,000 annually, and members' retainers will increase by $1,000 to $10,000 annually. These changes aim to further align compensation with the responsibilities of these key oversight roles, with no alterations to the equity award components.

Key Highlights

  • 1Titus Ball appointed as the new Principal Accounting Officer, effective March 19, 2024.
  • 2Julia Wang will continue as Chief Financial Officer and Principal Financial Officer, with Titus Ball taking over the Principal Accounting Officer duties.
  • 3Titus Ball has extensive experience, including roles at KPMG and Carlisle Companies Inc. (VP & Chief Accounting Officer).
  • 4BeiGene's Independent Director Compensation Policy has been amended.
  • 5The Nominating and Corporate Governance Committee's chairperson will receive an increased annual cash retainer of $20,000 (+$2,000).
  • 6Members of the Nominating and Corporate Governance Committee will receive an increased annual cash retainer of $10,000 (+$1,000).
  • 7The amended director compensation is effective April 1, 2024, with no changes to equity awards.

Frequently Asked Questions